Double blind, placebo-controlled, randomised clinical trial to evaluate the efficacy of co-trimoxazole given as prophylaxis in reducing mortality in human immunodeficiency virus-infected adults with tuberculosis

Completed

• Conditions: Tuberculosis and HIV/AIDS; Infections and Infestations; Tuberculosis

• Registration Number: ISRCTN15281875
• Lead Sponsor: niversity College London (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-05-11
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1045

Inclusion Criteria

1. Adults greater than 16 years old
2. HIV-infected
3. Newly diagnosed pulmonary tuberculosis
4. Had a permanent residential address
5. Not pregnant
6. Willing to give informed consent

Exclusion Criteria

1. Pregnant
2. Terminally ill World Health Organization (WHO) stage 4 patients
3. History of sulfonamide allergy
4. Already receiving co-trimoxazole

Study & Design

• Study Type: Interventional
• Study Design: Not specified